Lymfactin(TM) Found to Significantly Increase Growth of Lymphatic Vessels in Animal Study; Results Seen as "Pathway to a Breakthrough" for Breast Cancer Patients Who Would Benefit From Lymph Node Transfers for Lymphedema
September 23, 2011 05:00 ET
|
Laurantis Pharma
MALMO, SWEDEN--(Marketwire - Sep 23, 2011) - Laurantis Pharma, a privately held biotechnology company based in Finland, today announced that Lymfactin™, adenoviral VEGF-C growth factor...
VIRxSYS Issued Third U.S. Patent This Year for Its Spliceosome-Mediated RNA Trans-Splicing (SMaRT(TM)) Program; Breakthrough RNA Therapeutic Platform
September 22, 2011 08:00 ET
|
VIRxSYS Corporation
GAITHERSBURG, MD--(Marketwire - Sep 22, 2011) - VIRxSYS Corporation, a Maryland-based biotechnology company, today announced that the United States Patent and Trademark Office has issued a third...
Results From Phase IIB Placebo Controlled Study of Bionor Pharma's Vacc-4x Show Excellent Safety Profile, Statistically Significant Viral Load Reduction in Patients With HIV Who Suspend Antiretroviral Therapy
September 14, 2011 02:30 ET
|
BionorPharma
BANGKOK, THAILAND--(Marketwire - Sep 14, 2011) - Results from the furthest advanced study of a therapeutic vaccine candidate to treat people living with HIV/AIDS were announced at a news conference...
Bionor Pharma ASA Announces Exploratory Study of Its Lead Therapeutic HIV-Vaccine Candidate Vacc-4x in Combination With Leading Cancer Drug
August 25, 2011 08:00 ET
|
BionorPharma
OSLO, NORWAY--(Marketwire - Aug 25, 2011) - Bionor Pharma ASA (OSLO: BIONOR) announces plans to conduct an exploratory clinical study using Bionor Pharma's therapeutic HIV-vaccine candidate,...
Functional Cure in Non-Human Primates Achieved With Simian Version of VIRxSYS' HIV Vaccine VRX1273
July 18, 2011 08:00 ET
|
VIRxSYS Corporation
ROME and GAITHERSBURG, MD--(Marketwire - Jul 18, 2011) - Researchers from VIRxSYS Corporation, the Gaithersburg, Maryland-based biotechnology company, today presented data indicating that a simian...
New HIV Research Findings to Be Presented at NAPWA "Treatment Horizons: Pathways to a Functional Cure" Satellite Symposium, International AIDS Society, Rome
July 15, 2011 07:30 ET
|
National Association of People with AIDS
SILVER SPRING, MD and ROME--(Marketwire - Jul 15, 2011) - HIV researchers working towards developing potential functional cures from three continents will present new data that collectively light a...
Researchers to Present Results From Two VIRxSYS HIV Studies at the 6th International AIDS Society Meeting
June 28, 2011 10:06 ET
|
VIRxSYS Corporation
GAITHERSBURG, MD--(Marketwire - Jun 28, 2011) - VIRxSYS Corporation today announced that data from two HIV studies will be presented at the 6th International AIDS Society Conference on HIV...
NAPWA's 17th Annual National HIV Testing Day, June 27th, Promotes Over 100 Activities Nationwide That Offer Free, Lifesaving, HIV Testing
June 22, 2011 08:00 ET
|
National Association of People with AIDS
SILVER SPRING, MD--(Marketwire - Jun 22, 2011) - Tens of thousands of Americans are expected to be tested for HIV at events from coast to coast organized as part of the National Association of People...
NAPWA's 17th Annual National HIV Testing Day, June 27th, Promotes Over 100 Activities Nationwide That Offer Free, Lifesaving, HIV Testing
June 21, 2011 20:13 ET
|
National Association of People with AIDS
SILVER SPRING, MD--(Marketwire - Jun 21, 2011) - Tens of thousands of Americans are expected to be tested for HIV at events from coast to coast organized as part of the National Association of People...
Statement by National Association of People with HIV/AIDS Regarding the 30th Anniversary of HIV/AIDS
June 02, 2011 08:00 ET
|
National Association of People with AIDS
SILVER SPRING, MD--(Marketwire - Jun 2, 2011) - NOTE TO JOURNALISTS:
For poignant stories about the impact of the 30thAnniversary of HIV/AIDS, leadership from the largest and oldest advocacy...